Company
Canbud Distribution Corp
Headquarters: Toronto, ON, Canada
CEO: Mr. Sameet Kanade CPA, MBA
Canbud Distribution Corp Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Canbud Distribution Corporation, a science and technology company, engages in the cultivation, extraction, and distribution of hemp cannabinoids (CBD) products and ingredients. It offers plant-based protein products; mushroom based immune and nootropic cognitive enhancement products; and medicinal and wellness CBD and other cannabinoids-based products. It offers its products under the brands My SeeBD, My SeeBN, and My SeeBG. The company was formerly known as Cannabis Clonal Corporation. Canbud Distribution Corporation was founded in 2018 and is based in Toronto, Canada.
Stocks & Indices
Canbud Distribution Corp has the following listings and related stock indices.
Stock: CSE: CBDX wb_incandescent